. 2015 Apr 10;172(12):3177–3188. doi: 10.1111/bph.13121

Table 2.

Effects of chronic (7 weeks) treatment with antipsychotic and antidepressant drugs on SWD parameters recorded in WAG/Rij rats both on the last day of administration and after 2 weeks of treatment discontinuation

Animal group (n = 10)	nSWDs	dSWDs (s)	sSWD (s)
Recordings on last day of chronic (7 weeks) treatment
Control group	6.89 ± 0.76	28.53 ± 8.32	4.06 ± 1.75
QTP-treated group (10 mg·kg⁻¹ day⁻¹)	5.89 ± 1.11	25.51 ± 9.93	3.53 ± 0.47
HAL-treated group (1 mg·kg⁻¹ day⁻¹)	11.89 ± 1.11^*	73.51 ± 9.13^*	6.23 ± 0.75^*
RISP-treated group (0.5 mg·kg⁻¹ day⁻¹)	10.73 ± 1.16^*	65.88 ± 6.78^*	6.53 ± 0.47^*
FLX-treated group (10 mg·kg⁻¹ day⁻¹)	9.56 ± 1.72^*	67.33 ± 4.35^*	7.35 ± 1.43^*
FLX-treated group (30 mg·kg⁻¹ day⁻¹)	8.35 ± 0.59^*	79.23 ± 7.43^*	9.35 ± 0.94^*
DLX-treated group (10 mg·kg⁻¹ day⁻¹)	5.98 ± 0.84	26.73 ± 6.45	3.98 ± 0.56
DLX-treated group (30 mg·kg⁻¹ day⁻¹)	2.98 ± 0.21^*	9.23 ± 3.6^*	2.1 ± 0.5^*

Recordings at 2 weeks after termination of chronic treatment
Control group	6.36 ± 0.42	32.53 ± 7.93	5.21 ± 0.97
QTP-treated group (10 mg·kg⁻¹ day⁻¹)	5.4 ± 0.69	26.07 ± 6.5	4.56 ± 0.6
HAL-treated group (1 mg·kg⁻¹ day⁻¹)	5.89 ± 1.11	29.51 ± 9.93	5.08 ± 0.75
RISP-treated group (0.5 mg·kg⁻¹ day⁻¹)	5.73 ± 1.16	25.88 ± 6.78	4.53 ± 0.47
FLX-treated group (10 mg·kg⁻¹ day⁻¹)	4.98 ± 2.12	27.96 ± 5.05	4.9 ± 0.51
FLX-treated group (30 mg·kg⁻¹ day⁻¹)	5.82 ± 0.79	26.54 ± 2.62	4.45 ± 2.34
DLX-treated group (10 mg·kg⁻¹ day⁻¹)	6.33 ± 0.59	30.02 ± 7.01	5.02 ± 0.64
DLX-treated group (30 mg·kg⁻¹ day⁻¹)	4.99 ± 1.46	25.31 ± 7.48	4.31 ± 0.89

Data marked with

are significantly different (P < 0.05) from control group.